These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4644205)

  • 1. Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine.
    Barranco SC; Ho DH; Drewinko B; Romsdahl MM; Humphrey RM
    Cancer Res; 1972 Dec; 32(12):2733-6. PubMed ID: 4644205
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of arabinosylcytosine on cultured human lymphoma cells.
    Drewinko B; Ho DH; Barranco SC
    Cancer Res; 1972 Dec; 32(12):2737-42. PubMed ID: 4644206
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma.
    Hart JS; Ho DH; George SL; Salem P; Gottlieb JA; Frei E
    Cancer Res; 1972 Dec; 32(12):2711-6. PubMed ID: 4644204
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of 1- -D-arabinofuranosylcytosine-induced cell lethality.
    Karon M; Benedict WF; Rucker N
    Cancer Res; 1972 Dec; 32(12):2612-5. PubMed ID: 4674677
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of nuclear division and chromosomal abnormalities in cytochalasin B-treated normal and transformed cells.
    O'Neill FJ
    Front Biol; 1978; 46():217-55. PubMed ID: 352742
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture.
    Tanigawa N; Kern DH; Hikasa Y; Morton DL
    Cancer Res; 1982 Jun; 42(6):2159-64. PubMed ID: 7074595
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear changes in Friend erythroleukemia cells treated with arabinosylcytosine in vitro.
    Conforti A; Fragomele F; Modesti A; Lazzaro D
    Int J Tissue React; 1984; 6(2):111-21. PubMed ID: 6588045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro growth promotion in human malignant melanoma cells by fibroblast growth factor.
    Richmond A; Lawson DH; Nixon DW; Stevens JS; Chawla RK
    Cancer Res; 1982 Aug; 42(8):3175-80. PubMed ID: 6212117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DNA replication and growth of several human and murine neoplastic cells by aphidicolin without detectable effect upon synthesis of immunoglobulins and HLA antigens.
    Pedrali-Noy G; Belvedere M; Crepaldi T; Focher F; Spadari S
    Cancer Res; 1982 Sep; 42(9):3810-3. PubMed ID: 6809314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell morphology of a human diploid cell strain (WI-38) after treatment with arabinosylcytosine.
    Heneen WK; Nichols WW
    Cancer Res; 1967 Feb; 27(2):242-50. PubMed ID: 6018558
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo synchrony of solid B16 melanoma by cytosine arabinoside, an inhibitor of DNA synthesis.
    Gibson MH; Bertalanffy FD
    J Natl Cancer Inst; 1972 Oct; 49(4):1007-18. PubMed ID: 5084119
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell cycle dependence of chemically induced malignant transformation in vitro.
    Marquardt H
    Cancer Res; 1974 Jul; 34(7):1612-5. PubMed ID: 4857730
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of nitrous oxide on human cell lines.
    Kano Y; Sakamoto S; Sakuraya K; Kubota T; Kasahara T; Hida K; Suda K; Takaku F
    Cancer Res; 1983 Apr; 43(4):1493-6. PubMed ID: 6600961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.
    Barranco SC; Novak JK
    Cancer Res; 1974 Jul; 34(7):1616-8. PubMed ID: 4858112
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines.
    Tuszynski GP; Cossu G
    Cancer Res; 1984 Feb; 44(2):768-71. PubMed ID: 6581864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro.
    Shackney SE; Ford SS; Occhipinti SJ; Ritch PS; Riccardi R; Erickson BW
    Cancer Res; 1982 Nov; 42(11):4339-47. PubMed ID: 7127279
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of anchorage-independent growth of human melanoma cells by a monoclonal antibody to a chondroitin sulfate proteoglycan.
    Harper JR; Reisfeld RA
    J Natl Cancer Inst; 1983 Aug; 71(2):259-63. PubMed ID: 6576184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient exposure to cytarabine increases peptide growth factor receptor expression and tumorigenicity of melanoma cells.
    Caraglia M; Leardi AI; Improta S; Perin V; Ricciardi B; Arra C; Ferraro P; Fabbrocini A; Pinto A; Bianco AR; Tagliaferri P
    Anticancer Res; 1997; 17(4A):2369-75. PubMed ID: 9252649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of in vitro transformation and the early and late modes of DNA replication of uv-irradiated Syrian hamster cells by caffeine.
    Doniger J; DiPaolo JA
    Radiat Res; 1981 Sep; 87(3):565-75. PubMed ID: 7280186
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoplastic transformation of human lung fibroblast MRC-5 SV2 cells induced by benzo[a]pyrene and confluence culture.
    Zhu H; Gooderham N
    Cancer Res; 2002 Aug; 62(16):4605-9. PubMed ID: 12183415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.